Tyra Biosciences Inc (TYRA)

Nov 15, 2024

How to Take Advantage of moves in (TYRA) - Stock Traders Daily

Nov 15, 2024

Nov 15, 2024

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5%Here's Why - MarketBeat

Nov 15, 2024

Nov 15, 2024

Short Interest in Tyra Biosciences, Inc. (NASDAQ:TYRA) Drops By 20.0% - MarketBeat

Nov 15, 2024

Nov 14, 2024

Tyra Biosciences (NASDAQ:TYRA) Shares Gap UpWhat's Next? - MarketBeat

Nov 14, 2024

Nov 13, 2024

RA Capital Management, L.P. Increases Stake in Tyra Biosciences Inc - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Tyra Biosciences to Present FGFR Precision Medicine Updates at Major Healthcare Conferences | TYRA Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Equities Analysts Offer Predictions for TYRA FY2024 Earnings - MarketBeat

Nov 13, 2024

Nov 13, 2024

FMR LLC Increases Stake in Tyra Biosciences Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Tyra Biosciences stock target cut, retains buy rating on clinical data - Investing.com Canada

Nov 12, 2024

Nov 11, 2024

HC Wainwright Has Lowered Expectations for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat

Nov 11, 2024

Nov 10, 2024

Tyra Biosciences director Nina Kjellson sells $1.28 million in stock By Investing.com - Investing.com Australia

Nov 10, 2024

Nov 08, 2024

Tyra Biosciences’ Q3 2024: Clinical Progress and Financial Resilience - TipRanks

Nov 08, 2024

Nov 08, 2024

Tyra Biosciences director Nina Kjellson sells $1.28 million in stock - Investing.com

Nov 08, 2024

Nov 07, 2024

Tyra Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights - PR Newswire

Nov 07, 2024

Nov 06, 2024

Tyra Biosciences director Nina S. Kjellson sells shares worth $194k - Investing.com

Nov 06, 2024

Nov 05, 2024

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Auour Investments LLC - MarketBeat

Nov 05, 2024

Nov 04, 2024

Long Term Trading Analysis for (TYRA) - Stock Traders Daily

Nov 04, 2024

Nov 04, 2024

Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Insider Buying Activity - MarketBeat

Nov 04, 2024

Nov 02, 2024

Tyra Biosciences director Nina Kjellson sells $2.28m in stock By Investing.com - Investing.com Australia

Nov 02, 2024

Nov 02, 2024

Tyra Biosciences director Nina Kjellson sells $2.28m in stock - Investing.com

Nov 02, 2024

Nov 02, 2024

Tyra Biosciences, Inc. (NASDAQ:TYRA) CFO Purchases $152,000.00 in Stock - MarketBeat

Nov 02, 2024

Nov 01, 2024

Tyra Biosciences CFO Alan Fuhrman acquires $151,954 in stock By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

Tyra Biosciences CFO Alan Fuhrman acquires $151,954 in stock - Investing.com

Nov 01, 2024

Oct 29, 2024

Tyra Biosciences (NASDAQ:TYRA) Trading Down 10.2%Here's What Happened - MarketBeat

Oct 29, 2024

Oct 29, 2024

Tyra Biosciences advances with Phase 2 trial for achondroplasia treatment By Investing.com - Investing.com Australia

Oct 29, 2024

Oct 29, 2024

Tyra Biosciences advances with Phase 2 trial for achondroplasia treatment - Investing.com

Oct 29, 2024

Oct 29, 2024

Piper Sandler maintains Overweight on Tyra Biosciences stock By Investing.com - Investing.com Canada

Oct 29, 2024

Oct 28, 2024

Tyra Biosciences stock target lifted, retains buy on clinical trial data - Investing.com Canada

Oct 28, 2024

Oct 28, 2024

Tyra Biosciences (NASDAQ:TYRA) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat

Oct 28, 2024

Oct 28, 2024

FDA clears Tyra Biosciences' trial for dwarfism drug By Investing.com - Investing.com Australia

Oct 28, 2024

Oct 28, 2024

Tyra Biosciences (NASDAQ:TYRA) Price Target Raised to $32.00 at HC Wainwright - MarketBeat

Oct 28, 2024

Oct 28, 2024

FDA clears Tyra Biosciences' trial for dwarfism drug - Investing.com India

Oct 28, 2024

Oct 28, 2024

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301) - PR Newswire

Oct 28, 2024

Oct 25, 2024

Tyra Biosciences (NASDAQ:TYRA) Shares Gap DownWhat's Next? - MarketBeat

Oct 25, 2024

Oct 25, 2024

Tyra Biosciences' (TYRA) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat

Oct 25, 2024

Oct 25, 2024

Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday? - Benzinga

Oct 25, 2024

Oct 25, 2024

Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer - Marketscreener.com

Oct 25, 2024

Oct 25, 2024

(TYRA) Long Term Investment Analysis - Stock Traders Daily

Oct 25, 2024

Oct 24, 2024

Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC) - PR Newswire

Oct 24, 2024

Oct 23, 2024

Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet - MSN

Oct 23, 2024

Oct 23, 2024

Tyra Biosciences (NASDAQ:TYRA) Sets New 52-Week HighWhat's Next? - MarketBeat

Oct 23, 2024

Oct 23, 2024

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET - Marketscreener.com

Oct 23, 2024

Oct 23, 2024

Tyra Biosciences stock soars to 52-week high of $28.86 - Investing.com India

Oct 23, 2024

Oct 23, 2024

Tyra Biosciences stock soars to 52-week high of $28.86 By Investing.com - Investing.com South Africa

Oct 23, 2024

Oct 22, 2024

RA Capital Management, L.P. Reduces Stake in Tyra Biosciences Inc - Yahoo Finance

Oct 22, 2024

Oct 22, 2024

Insider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) CEO Sells 19,084 Shares of Stock - MarketBeat

Oct 22, 2024

Oct 21, 2024

Tyra Biosciences (NASDAQ:TYRA) Shares Up 4.2%Here's Why - MarketBeat

Oct 21, 2024